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Abstract 
 
Osteoporosis is a prevalent metabolic bone disease in the western world, resulting in low 
trauma fractures and increased morbidity and mortality rates among sufferers.  The article 
describes the common imaging required in the diagnosis and management of osteoporosis.  
It is important to include imaging within the patient pathway where vertebral fractures are 
suspected and to use additional imaging modalities such as MRI to aid differential diagnosis 
where the cause of the fracture is unclear.  Radiographers and radiologists reporting imaging 
examinations may be the first clinicians to suspect the presence of osteoporosis and have a 
role in helping to ensure that these patients do not get missed so that appropriate treatment 
can be started. Ideally there should be locally-agreed pathways whereby such patients are 
automatically referred to the fracture liaison service, regardless of the original requester of 
the imaging investigation. 
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Introduction 
Osteoporosis is a common metabolic bone disease in the elderly population within the UK 
and is characterised by reduced bone density and micro-architectural deterioration of bone.  
This results in an increased risk of fracture1 with one in two women and one in five men over 
the age of 50 sustaining a fracture, most of which are attributable to osteoporosis2.    
Osteoporosis is becoming an increasing public health issue in the UK, with the incidence 
predicted to increase by almost a fifth by 2020 in line with the aging population3.  Therefore, 
appropriate diagnosis, therapeutic intervention and monitoring is required to reduce the 
burden of osteoporosis-related fractures, including appropriate imaging to facilitate accurate 
diagnosis.  This paper will discuss the use of imaging in the differential diagnosis and 
monitoring of osteoporosis in an elderly population.   
 
Diagnosis 
Dual energy x-ray absorptiometry (DXA) currently provides the most widely accepted 
method for the assessment of osteoporosis4, with the world health organisation criteria for 
the diagnosis of osteoporosis being used as standard in postmenopausal women5.  
Screening for osteoporosis in the UK is not supported at present6 and therefore those at 
highest risk should be identified through clinical risk factors.  The FRAX tool can be used to 
identify those who require a DXA referral and also predicts fracture risk from the number of 
clinical risk factors in normal and obese female populations7, 8.  Falls history should also be 
considered alongside bone mineral density and clinical risk factors when deciding on 
therapeutic intervention, since it provides a further independent risk factor for fracture9.   
Patients presenting with a low trauma fracture or those who have notable x-ray osteopenia 
should also be referred for a DXA scan, with the former group attending the fracture liaison 
service if available.  X-ray osteopenia is demonstrated in figure one and can be noted by 
reduced cortical thickness with an associated appearance of reduced density and more 
prominent trabeculation being visualised on a radiograph, frequently providing less contrast 
between the bone and soft tissues than when compared to radiographs of normal density 
bone10. Whilst osteoporosis may be suspected from these plain radiographic findings this is 
not a reliable way of making the diagnosis and plain film radiography is not indicated purely 
to assess for bone density. On the other hand, plain films may be helpful in suggesting the 
diagnosis when there is new onset of pain and suspected osteoporotic vertebral fracture.  
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While DXA is the most commonly used tool, it has a number of limitations, including the 
spine measurements being confounded by degenerative changes and aortic calcification in 
elderly populations, along with difficulty positioning the hip where patients are unable to hold 
the required position well 11.  Obesity results in inaccuracies and poor precision in the spine 
and hip, with the most marked of these being at the spine due to tissue inhomogeneity12.  A 
fat paniculus can result in inaccuracies at the hip and retraction of this is advised where 
possible11.  Furthermore, large weight changes in either direction result in inaccuracies in 
measuring longitudinal changes in the hip and spine13, 14.  Despite these confounders, DXA 
is still a valuable tool in much of the elderly population.   
Vertebral fracture assessment 
Dual x-ray absorptiometry scanners can also be utilised for vertebral fracture assessment 
(VFA), as demonstrated in figure 2.  VFA provides a lateral image of T4 to L4, and has a 
significantly reduced dose compared to a thoraco-lumbar projection radiography series15.  It 
has been reported to have a high degree of accuracy for diagnosing fracture and in practice 
can increase the identification of vertebral fractures and altered patient management in 
those with unknown fractures16, 17.   The presence of a vertebral fracture can lead to pain, 
deformity and loss of function, but importantly is also a strong predictor of future fracture18.  
In 2000, it was estimated that less than 30% of vertebral fractures are diagnosed, thus 
improved strategies to identify those with vertebral fractures is of utmost importance19.  
Using VFA in practice has been demonstrated to increase the number of patients diagnosed 
with osteoporosis and requiring therapeutic intervention20 21. 
If a vertebral fracture is identified on a VFA scan, the international society for clinical 
densitometry (ISCD) recommends that routine x-rays are not required to confirm the fracture, 
but may be required to confirm an equivocal fracture, to differentiate between non-fracture 
deformities such as Scheuermanns’ disease or degenerative changes, or to examine for 
another pathology causing the fracture, for example Paget’s disease of bone or 
malignancy22.  Further imaging may be required where other underlying pathology is 
suspected and magnetic resonance imaging (MRI), CT, Nuclear Medicine or PET-CT may 
be used depending on the pathology suspected.  MRI and PET-CT in combination have 
been demonstrated to have high sensitivity and specificity for benign and malignant lesions 
in the spine, with 100% accuracy in the former23.  Figures 3a and 3b demonstrate a vertebral 
fracture resulting from metastatic disease. 
Painful vertebral fractures in which the patient continues to have pain despite optimal pain 
management24, should be investigated using clinical examination and or imaging to confirm 
the pain is at the site of the fracture.  Magnetic resonance imaging can be particularly useful 
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if considering a vertebroplasty or kyphoplasty25.  Figure 4 demonstrates a recent 
osteoporotic fracture which may be amenable to vertebroplasty.  Patients with osteoporosis 
suffering from low back and pelvis pain should have sacral insufficiency or stress fractures 
considered as part of their differential diagnosis.   These occasionally also occur in the final 
trimester of pregnancy and postpartum in younger women.  Plain film radiographs are 
frequently inconclusive in this condition, while CT or MRI provide better sensitivity and 
specificity, with MRI being considered the current gold standard26. 
 
Imaging of other osteoporotic fractures 
Osteoporosis can lead to fractures anywhere in the skeletal system, although fractures of the 
wrist, hip and vertebrae are the most commonly seen.27.  Plain film radiography is usually the 
first line method for imaging these fractures and in many cases is sufficient to make a 
diagnosis.  However, in some patients, occult fractures may be present.  These are of 
particular importance in the hip, where identifying the fracture quickly to ensure the patient 
reaches theatre on the day of or following admission is of utmost importance28.  Occult 
fractures of the hip (figure 5) may be present when the patient presents clinically with the 
signs and symptoms of a hip fracture, but the radiographic images fail to demonstrate this.  
In this case the ideal pathway providing the greatest diagnostic accuracy is to perform an 
MRI scan, where the bone marrow oedema associated with the occult fracture can confirm 
its presence29.  In patients who are not suitable for MRI, or where MRI is not available, 
computed tomography (CT) can be used as an alternative, though has a marginally poorer 
accuracy29, 30. 
 
Differential diagnosis 
The presence of apparent osteoporosis on a DXA measurement, with or without fracture, 
may not provide the definitive diagnosis.  Vitamin D deficiency is becoming increasingly 
prevalent among the elderly population within the UK and therefore osteomalacia should be 
ruled out by blood tests, particularly in those who are immobile and do not go outside often31.  
There are occasionally some findings in osteomalacia which are not seen in osteoporosis.  A 
“Looser’s zone” or pseudofracture, may be seen in osteomalacia along with reports of bone 
pain and muscle weakness32, which are not typical symptoms of osteoporosis33.   
 
6 
 
Multiple myeloma can cause lytic lesions, which improve with chemotherapy34 but the x-ray 
appearance may also be one of diffuse osteopenia, mimicking osteoporosis. There should 
be a low index of suspicion for this condition and patients with suspected Multiple Myeloma 
may be screened by blood tests looking for anaemia, abnormal protein levels and raised 
plasma viscosity and even further assessment of urine for Bence Jones protein and plasma 
electrophoresis where diagnosis is strongly suspected.  Finally, occasional anatomical 
anomalies are visualised on DXA scans which may or may not impact on the BMD results.  If 
these are unexplained, then further imaging may be required to investigate these.   
 
Longitudinal monitoring 
A diagnosis of osteoporosis requires the consideration of therapeutic intervention in line with 
national and local guidelines and in line with clinical decision making in relation to the clinical 
history of the patient35.  Longitudinal scans can be useful in a population with low bone 
density, where therapeutic intervention would not be indicated, but who may be at risk of 
developing osteoporosis in the future.  Once a patient is put onto a pharmacological 
intervention for osteoporosis, monitoring of their treatment response needs to be considered.  
The use of bisphosphonates, the most common first line treatment for osteoporosis is known 
to be linked with poor adherence and compliance36, 37.  Treatment monitoring therefore can 
be of benefit to check the compliance and adherence of the patient.  However, the use of 
DXA in treatment monitoring is often sub-optimal.  The time intervals required are generally 
between 18 to 24 months and in obese patients may be even greater12.  Biochemical 
markers of bone turnover are an appropriate alternative where available and can detect 
treatment response much more rapidly than DXA, with a reliable result just three months 
post commencing treatment38.   Monitoring of BMD five to ten years post commencing 
treatment is of particular use when considering a drug treatment holiday for patients on 
bisphosphonates to prevent the over suppression of bone turnover.  Further monitoring may 
be required during the treatment holiday when an increase in bone turnover markers and a 
reduction in BMD may signal the requirement to recommence treatment39. 
 
Bisphosphonates have been demonstrated to be effective at increasing BMD and reducing 
fractures by approximately 50% over 2 years of use40.  However, as the longevity of 
bisphosphonates has increased, adverse events in long-term users, generally of greater 
than five years have been reported.  Atypical fractures of the femora (figure 6) in men and 
women have been reported in a number of studies.  These fractures share a common 
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appearance, with periosteal thickening as often seen in stress fractures.  The fractures also 
tend to be transverse and in the upper third of the femur41 42.  Plain film radiography is the 
most common method for diagnosing these fractures and additional imaging is rarely 
required; the important thing is for radiologists and physicians to be aware of the plain film 
findings and to suspect the condition when patients on bisphosphonate therapy present with 
new hip or thigh pain. If there is doubt on the plain films MRI may be helpful. 
Osteonecrosis of the jaw (ONJ) is a rare, but notable complication of those on long term and 
especially high dose bisphosphonates, such as those with metastatic bone disease43.  
Imaging for this is required to ascertain the extent and differentiate from metastatic disease.  
Nuclear medicine scintigraphy provides the ability for early diagnosis and other imaging may 
include dental radiographs, orthopantomographs (OPG’s), MRI and CT to investigate the 
extent and assist in differential diagnosis of ONJ44. 
 
Conclusion 
In conclusion, imaging plays an integral role in the diagnosis and management of 
osteoporosis, osteoporotic fractures and the complications associated with bisphosphonate 
treatment.  It is important to include imaging within the patient pathway where vertebral 
fractures are suspected and to use additional imaging modalities such as MRI to aid 
differential diagnosis where the cause of the fracture is unclear.  Radiographers and 
radiologists reporting imaging examinations may be the first clinicians to suspect the 
presence of osteoporosis and have a role in helping to ensure that these patients do not get 
missed so that appropriate treatment can be started. Ideally there should be locally-agreed 
pathways whereby such patients are automatically referred to the fracture liaison service, 
regardless of the original requester of the imaging investigation. 
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Figure 1:  Plain film of typical osteoporotic vertebral fracture and demonstrating x-ray osteopenia 
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Figure 2:  GE Lunar Prodigy dual energy lateral vertebral assessment scan, utilising 
morphometric software to indicate fracture presence and grade.  
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Figure 3: MRI of vertebral fracture from metastasis 
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Figure 3b: MRI of vertebral fracture from metastasis 
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Figure 4: MRI showing recent OP fracture (and old fractures) which may be amenable to 
vertebroplasty 
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Figure 5: MRI showing occult femoral neck fracture 
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Figure 6: Plain film of atypical femoral fracture 
 
 
